Effect of 12-week FW Programme on Sex Hormone Levels and Risk Factors for MS in Postmenopausal Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-16

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postmenopausal women were separated into two groups: one participating in a 12-week fitness walking programe as the fitness walking group, and the other maintaining their regular lifestyle as the control group. The study evaluated alterations in health markers and examined the correlation between metabolic syndrome risk factors and sex hormone levels before and after the intervention.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physical Activity and Metabolic Risk Factors in Postmenopausal Women

NCT01259661

Postmenopausal Women

UNKNOWN NA

The Impact of Exercise Methods on Human Body Functions and Metabolism

NCT06523790

Metabolic Syndrome

RECRUITING NA

Effects of Normobaric Hypoxia Exercise Program on Bone Turnover Markers and Metabolism in Premenopausal Women

NCT06226168

Hypoxia

RECRUITING NA

High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women

NCT07302191

Women Veterans Obese Women Postmenopausal +1 more

COMPLETED NA

12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women

NCT04014686

Metabolic Syndrome Dyslipidemias Insulin Resistance +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

According to the inclusion and exclusion criteria, our study invlved postmenopausal women aged from 50 to 69 years old. After the selection process, baseline assessments were conducted, including evaluations of metabolic syndrome risk factors, body morphology measurements, sex hormone levels, and cardiopulmonary exercise testing. Participants were then randomly assigned to either the fitness walking group or the control group using a random number table. Participants in the fitness walking group completed a 12-week fitness walking program, while those in the control group maintained their usual lifestyle without any intervention. During the post-intervention assessment, all baseline measurements were repeated to evaluate changes in the previously measured indicators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postmenopause Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fitness walking group

Group Type EXPERIMENTAL

Fitness walking

Intervention Type BEHAVIORAL

Fitness walking for 12 weeks.

Control group

Group Type SHAM_COMPARATOR

Maintained lifestyle

Intervention Type BEHAVIORAL

Maintained their normal lifestyle, without exercise intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fitness walking

Fitness walking for 12 weeks.

Intervention Type BEHAVIORAL

Maintained lifestyle

Maintained their normal lifestyle, without exercise intervention.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (1) Participants were entirely voluntary and capable of completing the full 12-week intervention process.
* (2) Participants were postmenopausal women aged between 50 and 69 years.
* (3) Participants had been postmenopausal for over 12 months and had not received exogenous estrogen supplementation post-menopause.

Exclusion Criteria

* (1) Participants had a history of acute or chronic musculoskeletal disorders, cardiovascular diseases, diabetes, or other conditions that might impact their ability to engage in the intervention.
* (2) Participants had recent hormone treatment, anti-inflammatory medication use, or other medications affecting blood indices.
* (3) Participants experienced unstable body weight (fluctuations exceeding 2.5 kg) in the past three months.
* (4) Participants were concurrently enrolled in other intervention studies or maintained regular exercise routines.
* (5) Participants had smoking or alcohol consumption habits.

Minimum Eligible Age

50 Years

Maximum Eligible Age

69 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes